Decreasing Clostridium difficile–Associated Fatality Rates Among Hospitalized Patients in the United States: 2004-2014

American Journal of Medicine

Volumn 131, Issue 1, 2018, Pages 90-96

  Shrestha, Manish P ^a   Bime, Christian ^a   Taleban, Sasha ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Clostridium difficile infection; Hospital charges; In hospital fatality; Length of stay

Indexed keywords

ADULT; AGED; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE ASSOCIATION; FEMALE; HOSPITAL CHARGE; HOSPITAL MORTALITY; HOSPITAL PATIENT; HUMAN; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; PRIORITY JOURNAL; UNITED STATES; AGING; CLOSTRIDIUM INFECTION; ECONOMICS; MIDDLE AGED; MORTALITY; PEPTOCLOSTRIDIUM DIFFICILE; VERY ELDERLY;

ANTIINFECTIVE AGENT;

AGED; AGED, 80 AND OVER; AGING; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; UNITED STATES;

EID: 85029506151     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2017.07.022     Document Type: Article

References (35)

1. Lessa, F.C., Winston, L.G., McDonald, L.C., Emerging Infections Program C. difficile Surveillance Team. Burden of Clostridium difficile infection in the United States. N Engl J Med 372:24 (2015), 2369–2370.
2. Kwon, J.H., Olsen, M.A., Dubberke, E.R., The morbidity, mortality, and costs associated with Clostridium difficile infection. Infect Dis Clin North Am 29:1 (2015), 123–134.
3. Dubberke, E.R., Olsen, M.A., Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 55:suppl 2 (2012), S88–S92.
4. Redelings, M.D., Sorvillo, F., Mascola, L., Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 13:9 (2007), 1417–1419.
5. Zilberberg, M.D., Shorr, A.F., Kollef, M.H., Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 14:6 (2008), 929–931.
6. McDonald, L.C., Killgore, G.E., Thompson, A., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353:23 (2005), 2433–2441.
7. Cecil, J.A., Clostridium difficile: changing epidemiology, treatment and infection prevention measures. Curr Infect Dis Rep 14:6 (2012), 612–619.
8. Surawicz, C.M., Brandt, L.J., Binion, D.G., et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108:4 (2013), 478–498 quiz 499.
9. JCAHO approves national patient safety goals for 2003. Jt Comm Perspect 22:9 (2002), 1–3.
10. Dellit, T.H., Owens, R.C., McGowan, J.E. Jr, et al. Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:2 (2007), 159–177.
11. Centers for Medicare & Medicaid Services, Hospital-acquired conditions (present on admission indicator). Available at: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HospitalAcqCond/index.html?redirect=/HospitalAcqCond/06_Hospital-Acquired_Conditions.asp. (Accessed 24 April 2017)
12. Sydnor, E.R., Perl, T.M., Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev 24:1 (2011), 141–173.
13. Kociolek, L.K., Gerding, D.N., Breakthroughs in the treatment and prevention of Clostridium difficile infection. Nat Rev Gastroenterol Hepatol 13:3 (2016), 150–160.
14. Houchens, R., Ross, D., Elixhauser, A., Jiang, J., Nationwide inpatient sample (NIS) redesign final report. HCUP methods series report # 2014-14. Online April 4, 2014. US Agency for Healthcare Research and Quality; Available at: http://www.hcup-us.ahrq.gov/reports/methods/methods.jsp. (Accessed 19 February 2017)
15. Elixhauser, A., Jhung, M., Clostridium difficile-associated disease in U.S. hospitals, 1993-2005. HCUP statistical brief #50. Available at: https://www.hcup-us.ahrq.gov/reports/statbriefs/sb50.pdf. (Accessed 19 February 2017)
16. United States Census Bureau, Population and housing unit estimates. Available at: https://census.gov/programs-surveys/popest/data/data-sets.html. (Accessed 12 April 2017)
17. StataCorp, Stata Statistical Software: Release 12. 2011, StataCorp, College Station, TX.
18. Reveles, K.R., Lee, G.C., Boyd, N.K., Frei, C.R., The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010. Am J Infect Control 42:10 (2014), 1028–1032.
19. Barrett, M., Wilson, E., Whalen, D., 2007 HCUP Nationwide Inpatient sample (NIS) comparison report. HCUP methods series report # 2010-03. Online September 9, 2010. US Agency for Healthcare Research and Quality; Available at: http://www.hcupus.ahrq.gov/reports/methods.jsp. (Accessed 12 April 2017)
20. Dubberke, E.R., Reske, K.A., McDonald, L.C., Fraser, V.J., ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis 12:10 (2006), 1576–1579.
21. Miller, M., Gravel, D., Mulvey, M., et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 50:2 (2010), 194–201.
22. Kallen, A.J., Thompson, A., Ristaino, P., et al. Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infect Control Hosp Epidemiol 30:3 (2009), 264–272.
23. Valiquette, L., Cossette, B., Garant, M.P., Diab, H., Pepin, J., Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 45:suppl 2 (2007), S112–S121.
24. Wilcox, M.H., Shetty, N., Fawley, W.N., et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin Infect Dis 55:8 (2012), 1056–1063.
25. Zillich, A.J., Sutherland, J.M., Wilson, S.J., et al. Antimicrobial use control measures to prevent and control antimicrobial resistance in US hospitals. Infect Control Hosp Epidemiol 27:10 (2006), 1088–1095.
26. Johannsson, B., Beekmann, S.E., Srinivasan, A., Hersh, A.L., Laxminarayan, R., Polgreen, P.M., Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers. Infect Control Hosp Epidemiol 32:4 (2011), 367–374.
27. Stone, P.W., Pogorzelska, M., Graham, D., Jia, H., Uchida, M., Larson, E.L., California hospitals response to state and federal policies related to health care-associated infections. Policy Polit Nurs Pract 12:2 (2011), 73–81.
28. American Society for Microbiology, A practical guidance document for the laboratory detection of toxigenic Clostridium difficile. Available at: https://www.asm.org/images/pdf/Clinical/clostridiumdifficile9-21.pdf. (Accessed 1 March 2017)
29. van Nood, E., Vrieze, A., Nieuwdorp, M., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368:5 (2013), 407–415.
30. Cohen, J., Limbago, B., Dumyati, G., et al. Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States. J Clin Microbiol 52:2 (2014), 632–634.
31. Gould, C.V., Edwards, J.R., Cohen, J., et al. Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis 57:9 (2013), 1304–1307.
32. Longtin, Y., Trottier, S., Brochu, G., et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis 56:1 (2013), 67–73.
33. Moehring, R.W., Lofgren, E.T., Anderson, D.J., Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-associated incidence rates. Infect Control Hosp Epidemiol 34:10 (2013), 1055–1061.
34. Moore, B., Levit, K., Elixhauser, A., Costs for hospital stays in the United States, 2012. HCUP statistical brief #181. Agency for Healthcare Research and Quality; Available at: https://www.hcup-us.ahrq.gov/reports/statbriefs/sb181-Hospital-Costs-United-States-2012.pdf. (Accessed 30 April 2017)
35. Lucado, J., Gould, C., Elixhauser, A., Clostridium difficile infections (CDI) in hospital stays, 2009: HCUP statistical brief #124. Agency for Healthcare Research and Quality; Available at: https://www.hcup-us.ahrq.gov/reports/statbriefs/sb124.pdf. (Accessed 30 April 2017)